US Patent Issued to FLAMEL IRELAND on Sept. 8 for "Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" (French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,110, issued on Sept. 8, was assigned to FLAMEL IRELAND Ltd. (Dublin).

"Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" was invented by Claire Megret (Lyons, France), Herve Guillard (Villeurbanne, France), Jean-Francois Dubuisson (Lyons, France) and Jordan Dubow (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof."

The patent was filed on Sept. 22, 2025, under Application No. 19/335,896.

*For further information, including images, charts and table...